COMPRESSION THERAPY MARKET ANALYSIS

Compression therapy uses controlled pressure to increase blood flow in the legs and improve blood flow to the heart. Simultaneously, it supports the veins and decreases swelling.

Types of compression:

• Compression Stocking
• Compression Wraps
• Mechanical Compression Devices

Compression therapy products are used to treat various diseases which includes varicose vein, deep vein thrombosis, lymphedema, and leg ulcers.     

Compression therapy involves products such as compression garments, compression stocking, compression bandages, compression tapes, and compression pumps.

Compression therapy market is estimated to be valued at US$ 3,336.4 million in 2022 and is expected to exhibit a CAGR of 5.9 % over the forecast period (2022-2030)

Figure 1. Global Compression Therapy Market Value (US$ Mn), By Region, 2022

To learn more about this report, request a free sample copy

Increasing venous diseases patients worldwide is expected to drive growth of the global compression therapy market over the forecast period.

For instance, according to an article published in Annals of Vascular Surgery in December 2021, a total of 869,220 surgeries were performed to treat chronic venous diseases over twelve years of span from 2008-2019 in Brazil, with an overall rate of 4.52 procedures per 10,000 population per year.

Figure 2. Global Compression Therapy Market Share (%), By Product Type, 2022

To learn more about this report, request a free sample copy

Increasing product launches and approvals are expected to drive market growth over the forecast period.

For instance, in April 2018 Tactile Systems Technology, Inc. a company which develops and markets at home therapy devices that treat lymphedema and chronic venous insufficiency had launched next generation Flexitouch system: Flexitouch plus. Flexitouch plus was the third generation of the company’s Flexitouch system and featured several key enhancements over prior generations, specifically the Flexitouch plus system’s controller, which had enhanced with a color display, the systems enhanced controller also enabled patients to treat two legs simultaneously, allowing them to complete bilateral therapy in less time. Moreover, the Flexitouch plus systems garments had been redesigned to provide improved fit, comfort and coverage and allow patients to wear it easily.

Moreover, AIROS Medical, Inc., a medical technology manufacturer specializing in compression therapy products, announced the launch of its updated AIROS 6 Sequential Compression Therapy device and Arm Plus garments (U.S. Food and Drug Administration (FDA) 510(k) cleared). The AIROS 6 uses pneumatic air compression to inflate accessory garments worn on the affected area of the body. It is used for the treatment of lymphedema in the arm, shoulder, chest, and back.

Global Compression Therapy Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 a pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 545,226,550 cases of coronavirus disease (COVID-19) were reported till 1 July, 2022, across the globe.

The present global COVID-19 epidemic has had a substantial influence on markets in a variety of sectors. In terms of global economic conditions, the geographical impact of the pandemic on enterprises, government laws and preventive regulations, demand from end users, supply chain and logistics issues, and the majority of industries are undergoing a moment of uncertainty.

Increasing in venous problems in hospitalized patients as a result of sleeping in one position for a long time during their hospital stay, Covid-19 has had a substantial impact on compression therapy market growth.

For instance, according to the study published in Plos One, titled 'Upper extremity deep vein thrombosis (UEDVT) in COVID-19: Incidence and correlated risk factors in a cohort of non-Intensive care unit (ICU) patients' in January 2022, despite sufficient prophylaxis, UEDVT can develop in COVID-19 patients, particularly those who use helmet continuous positive airway pressure (CPAP) ventilation therapy.

The private healthcare sector is facing challenges such as investing additional manpower, equipment, consumables, and other resources to ensure 100% preparedness for safety in hospitals and the eventual treatment of patients needing compression therapy, alongside the sharp drop in out-patient facilities, surgeries, and international patients.

Global Compression Therapy Market Restraint

Several alternative therapies have advantages over compression therapy, such as fewer or no side effects, reduced pain during and after treatment, and a shorter hospital stay.

Moreover, unlike compression therapy, these alternative therapies address the entire disease rather than just the symptoms. Laser and radiofrequency ablation, for example, are frequently used to treat varicose veins.

Key Players

Major players operating in the global compression therapy market are BSN medical, SIGVARIS, medi GmbH & CO KG, Actile Medical, Innothera, PAUL HARTMANN AG, DJO Global, Inc., Devon Medical Products, ElastiMed, KT Health, IntelliSkin, 3M, Biocompression Systems, Inc., Medtronic and Other prominent players.